» Articles » PMID: 15324701

Hepsin Promotes Prostate Cancer Progression and Metastasis

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2004 Aug 25
PMID 15324701
Citations 101
Authors
Affiliations
Soon will be listed here.
Abstract

The majority of cancer-related deaths are associated with metastasis; however, little is known about the mechanisms of this process. Hepsin is a cell surface serine protease that is markedly upregulated in human prostate cancer; however, the functional significance of this upregulation is unknown. We report here that hepsin overexpression in prostate epithelium in vivo causes disorganization of the basement membrane. Overexpression of hepsin in a mouse model of nonmetastasizing prostate cancer has no impact on cell proliferation, but causes disorganization of the basement membrane and promotes primary prostate cancer progression and metastasis to liver, lung, and bone. We provide in vivo evidence that upregulation of a cell surface serine protease in a primary tumor promotes cancer progression and metastasis.

Citing Articles

From biology to the clinic - exploring liver metastasis in prostate cancer.

Ni X, Wei Y, Li X, Pan J, Fang B, Zhang T Nat Rev Urol. 2024; 21(10):593-614.

PMID: 38671281 DOI: 10.1038/s41585-024-00875-x.


Hepsin promotes breast tumor growth signaling via the TGFβ-EGFR axis.

Belitskin D, Munne P, Pant S, Anttila J, Suleymanova I, Belitskina K Mol Oncol. 2023; 18(3):547-561.

PMID: 37872868 PMC: 10920082. DOI: 10.1002/1878-0261.13545.


The roles of proteases in prostate cancer.

Koistinen H, Kovanen R, Hollenberg M, Dufour A, Radisky E, Stenman U IUBMB Life. 2023; 75(6):493-513.

PMID: 36598826 PMC: 10159896. DOI: 10.1002/iub.2700.


Preclinical Models of Neuroendocrine Neoplasia.

Sedlack A, Saleh-Anaraki K, Kumar S, Ear P, Lines K, Roper N Cancers (Basel). 2022; 14(22).

PMID: 36428741 PMC: 9688518. DOI: 10.3390/cancers14225646.


In Vivo Models for Prostate Cancer Research.

Adamiecki R, Hryniewicz-Jankowska A, Ortiz M, Li X, Porter-Hansen B, Nsouli I Cancers (Basel). 2022; 14(21).

PMID: 36358740 PMC: 9654339. DOI: 10.3390/cancers14215321.